Skip to main content

9 Result(s)

within Article Remove this filter Steve Shivers PhD Remove this filter

and

  1. No Access

    Article

    ASO Visual Abstract: The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy

    Peter Blumencranz MD, Mehran Habibi MD, Steve Shivers PhD… in Annals of Surgical Oncology (2024)

  2. Article

    Open Access

    The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy

    Neoadjuvant chemotherapy (NCT) increases the feasibility of surgical resection by downstaging large primary breast tumors and nodal involvement, which may result in surgical de-escalation and improved outcomes...

    Peter Blumencranz MD, FACS, Mehran Habibi MD… in Annals of Surgical Oncology (2023)

    Download PDF (570 KB) View Article

  3. Article

    Correction to: The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery

    A correction to this paper has been published: https://doi.org/10.1245/s10434-021-10138-3

    Chirag Shah MD, Troy Bremer PhD, Charles Cox MD… in Annals of Surgical Oncology (2021)

    Download PDF (145 KB) View Article

  4. Article

    Open Access

    The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery

    The role of radiation therapy (RT) following breast-conserving surgery (BCS) in ductal carcinoma in situ (DCIS) remains controversial. Trials have not identified a low-risk cohort, based on clinicopathologic f...

    Chirag Shah MD, Troy Bremer PhD, Charles Cox MD… in Annals of Surgical Oncology (2021)

    Download PDF (307 KB) View Article

  5. No Access

    Article

    Evidence for a Better Nodal Staging System for Melanoma: The Clinical Relevance of Metastatic Disease Confined to the Sentinel Lymph Nodes

    The hypothesis tested in this study was whether patients with stage III metastatic melanoma confined to their sentinel lymph nodes (SLNs) had a more favorable prognosis than patients who had SLN and non-SLN (N...

    Michael Reintgen, Lauren Murray, Kurt Akman… in Annals of Surgical Oncology (2013)

  6. No Access

    Article

    The Number of Lymph Nodes Involved with Metastatic Disease Does Not Affect Outcome in Melanoma Patients as Long as All Disease Is Confined to the Sentinel Lymph Node

    In melanoma, a direct relationship exists between the number of nodes involved with metastatic disease and prognosis. This study was undertaken to determine whether an individual with metastatic disease confin...

    James W. Jakub MD, Marianne Huebner PhD, Steve Shivers PhD… in Annals of Surgical Oncology (2009)

  7. No Access

    Article

    Molecular Staging of Melanoma

    Steve Shivers PhD, Marwan Alsarraj MS… in Annals of Surgical Oncology (2004)

  8. No Access

    Article

    The staging of malignant melanoma and the florida melanoma trial

    Lymphatic map** and sentinel lymph node (SLN) biopsy have changed the standard of care for patients with malignant melanoma, by providing a less morbid procedure to obtain the nodal staging information that ...

    Douglas S. Reintgen MD, James W. Jakub MD, Solange Pendas MD… in Annals of Surgical Oncology (2004)

  9. No Access

    Article

    Final results of the department of defense multicenter breast lymphatic map** trial

    Lymphatic map** and sentinel lymph node (SLN) biopsy have the potential to become the standard of care for nodal staging in breast cancer patients, but their widespread utility outside of university-based ce...

    Steve Shivers PhD, Charles Cox MD, George Leight MD… in Annals of Surgical Oncology (2002)